Single-cell transcriptomic analysis of the senescent microenvironment in bone metastasis

• Published in: Cell proliferation 2024-09, p.e13743
• Main Authors: Wang, Shenglin, Ao, Lu, Lin, Huangfeng, Wei, Hongxiang, Wu, Zhaoyang, Lu, Shuting, Liang, Fude, Shen, Rongkai, Zhang, Huarong, Miao, Tongjie, Shen, Xiaopei, Lin, Jianhua, Zhong, Guangxian
• Format: Article
• Language: English
• ISSN: 0960-7722; 1365-2184; 1365-2184
• DOI: 10.1111/cpr.13743

Bone metastasis (BM) is a mortality-related event of late-stage cancer, with non-small cell lung cancer (NSCLC) being a common origin for BM. However, the detailed molecular profiling of the metastatic bone ecosystem is not fully understood, hindering the development of effective therapies for advanced patients. In this study, we examined the cellular heterogeneity between primary tumours and BM from tissues and peripheral blood by single-cell transcriptomic analysis, which was verified using multiplex immunofluorescence staining and public datasets. Our results demonstrate a senescent microenvironment in BM tissues of NSCLC. BM has a significantly higher infiltration of malignant cells with senescent characteristics relative to primary tumours, accompanied by aggravated metastatic properties. The endothelial-mesenchymal transition involved with SOX18 activation is related to the cellular senescence of vascular endothelial cells from BM. CD4Tstr cells, with pronounced stress and senescence states, are preferentially infiltrated in BM, indicating stress-related dysfunction contributing to the immunocompromised environment during tumour metastasis to bone. Moreover, we identify the SPP1 pathway-induced cellular crosstalk among T cells, vascular ECs and malignant cells in BM, which activates SOX18 and deteriorates patient survival. Our findings highlight the roles of cellular senescence in modulating the microenvironment of BM and implicate anti-senescence therapy for advanced NSCLC patients.